Novanta Inc., a Nasdaq-listed technology partner to medical and advanced technology equipment manufacturers, has launched and priced a public offering of 11,000,000 tangible equity units at US$50.00 per unit, for an aggregate stated amount of US$550.0 million. The units consist of 6.50 percent tangible equity units comprising stock purchase contracts and senior amortizing notes, with equal quarterly cash installments of US$0.8125 per amortizing note (US$0.7132 for the first payment), equating to 6.50 percent per year on the US$50.00 stated amount. Novanta expects net proceeds of approximately US$533.0 million, or up to about US$613.2 million if the underwriters exercise a 30-day option to purchase up to an additional 1,650,000 units. The company plans to use a portion of the proceeds to repay approximately US$317 million of indebtedness under its revolving credit facility, with the balance for working capital, potential acquisitions and investments, capital expenditures, share repurchases and other general corporate purposes. J.P. Morgan, BofA Securities and Wells Fargo Securities are acting as joint book-running managers.